Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the Glialia Supplement in the Treatment of Persistent Perceptual Postural Imbalance: A Triple-Blind, Randomized, Placebo-Controlled Pilot Clinical Trial

NCT06741358 is registered in ClinicalTrials.gov with I.R.C.C.S. Fondazione Santa Lucia as lead sponsor.

NCT NCT06741358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06741358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the Glialia Supplement in the Treatment of Persistent Perceptual Postural Imbalance: A Triple-Blind, Randomized, Placebo-Controlled Pilot Clinical Trial
Lead sponsor
I.R.C.C.S. Fondazione Santa Lucia
Phase
Phase 4
Overall status
Recruiting
Start date
December 21, 2024
Completion date
May 10, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

persistent postural perceptual dizziness